6 completed, 1 not yet recruiting. 7 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 6, Not yet recruiting 1 |
Follow dienogest: new trials by email Literature Review of dienogest trials Research Report on dienogest
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ttt of Adenomyosis Dienogest 2 mg orally, UAE - Adenomyosis | Phase 1 | Not yet recruiting | Al-Azhar University | 100 | 2025-01-01 | 2024-12-06 |
| Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product Estradiol Valerate and Dienogest 2 mg/ 2 mg Test Drug tablet, Estradiol Valerate and Dienogest 2 mg/ 2 mg Reference Product tablet - Bioequivalence | Phase 1 | Completed | Laboratorios Andromaco S.A. | 10 | 2022-03-12 | 2022-04-18 |
| Bioavailability of Dienogest 2.0 mg With Regards to Reference Product Dienogest 2.0 mg Test Drug, Dienogest 2.0 mg Reference Product - Bioequivalence | Phase 1 | Completed | Laboratorios Andromaco S.A. | 30 | 2019-12-07 | 2020-01-18 |
| Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Dienogest 2.0 mg and Ethinyl estradiol 0.03 mg Reference Product - Bioequivalence | Phase 1 | Completed | Laboratorios Andromaco S.A. | 10 | 2019-11-09 | 2019-12-10 |
| Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam levonorgestrel/ Microlut, Norethindrone/ Noriday, Desogestrel/ Cerazette - Biological Availability | Phase 1 | Completed | Bayer | 68 | 2017-11-29 | 2020-04-15 |
| Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium BAY 98-7079, Estradiolvalerate (EV) / Dienogest (DNG) / Levomefolate calcium, BAY 86-5027,Estradiolvalerate(EV) / Dienogest (DNG), BAY 86-7660,levomefolate calcium - Pharmacology, Clinical | Phase 1 | Completed | Bayer | 43 | 2009-09-01 | 2016-08-01 |
| Pharmacodynamic Characterization of Dienogest Dienogest (81150037), Dienogest (81150231), Dienogest (SH T00660A) - Pharmacodynamics | Phase 1 | Completed | Bayer | 102 | 2008-09-01 | 2015-01-27 |
Adenomyosis (1)
Bayer (3) · Laboratorios Andromaco S.A. (3) · Al-Azhar University (1)
Chile (2) · Germany (2) · Egypt (1) · India (1) · Netherlands (1)
R. Amirtha, MD (1)
2008 (1), 2009 (1), 2017 (1)